KA Imaging

www.kaimaging.com
Innovation Type:
Medical Technologies
Cancer Type:
Other
Funding Stage:
Series A
Fund:
Compass Rose, Prospects
World’s first and only portable dual-energy detector, enabling bone and soft tissue differentiation in a single, highly sensitive x-ray exposure.

Related news

FACIT Features: Portfolio company KA Imaging launches first-in-human pilot study to test lung screening x-ray

KA Imaging, a recent Prospects Fund recipient, is partnering with Grand River Hospital to conduct a pilot study on the use of a high-resolution multi-energy digital x-ray imager for patients with lung nodules. Read More

FACIT Features: Portfolio company KA Imaging secures FDA approval for portable dual-energy x-ray detector

September 17, 2020 – Since FACIT’s early seed investment in KA Imaging, the company has greatly expanded its IP portfolio, as well as the number of highly skilled jobs it has brought to Ontario. Read More

FACIT Features: Portfolio company KA Imaging secures Series A financing and new global strategic partner

October 24, 2019 – New partnership will provide the Ontario-based start up with both capital and advanced manufacturing expertise to accelerate its portable multi-energy x-ray detector technology. Read More

FACIT Announces Investment in 3 Ontario Start-ups Under Prospects Fund

Ontario start-ups Radialis Medical of Thunder Bay, KA Imaging of Kitchener, and DNAstack of Toronto are the first to receive capital from FACIT's new Prospects Oncology Fund for proof-of-concept development of breakthrough cancer technologies. Read More

    CONNECT WITH FACIT

    Learn more about how we are driving made-in-Ontario oncology innovations reach the market.